Rimonabant was not approved by the FDA due to concerns about suicidal tendencies in patients. Sanofi-Aventis had hoped to release Rimonabant as a weight loss drug.
Acomplia Rimonabant diet pill is the most popular and successful weight loss drugs in United Kingdom that saved life of thousands of patients from a harmful and hazardous disease called obesity . Generally Acomplia Rimonabant is a CB1 blocker which offers solution to improve a variety of cardiometabolic risk factors in overweight and obese patients. These risk factors include hypertension,diabetes, high LDL cholesterol levels and other factors being investigated as insulin resistance, low... Read Full Story
A new anti-obesity pill that has been shown to not only help lose weight and quit smoking could also be effective in helping people stop drug and alcohol addiction, scientists claim.
Acomplia, or rimonabant, is an experimental drug developed by the French pharmaceutical firm Sanofi-Aventis primarily as a diet pill, but the drug works differently that most diet pills in that it blocks the brain’s reward system.
It works by blocking the connection between a pleasure-seeking activity... Read Full Story
Rimonabant is an anorectic anti- obesity drug. It works by suppressing our appetite making the stomach feel full. It is a cannabinoid receptor antagonist which blocks a special type of receptors called the CB1 receptors found in the nervous system. On the other hand, it is found that it also acts as smoking cessation agent. It is developed from the knowledge that cannabis smokers often experience extreme hunger ripples. So, researchers worked on the premise that if cannabinoid stimulates... Read Full Story
A WEIGHT loss pill used by thousands of dieters has been branded a suicide risk by drug safety officials.
Some 37,000 Britons are taking the prescription-only drug Acomplia , which can help users lose up to 10 per cent of their body weight.
Hailed as an important weapon in the war against obesity, it interferes with the part of the brain involved with cravings.
But yesterday a committee advising the U.S. Food and Drug Administration voted to ban the pill after concerns about its... Read Full Story
21st June 2006. For most people, the day was just like any other day, holding not much importance. But for obese people in the UK, the day will be ever remembered. For on this day, Acomplia, the wonder drug for obesity was released for sale on prescription. Research on acomplia as a diet pill was going on for years. And all eyes were on when the wonder drug will be released.
After Fen-phen, Acomplia diet pill was the most anticipated drug and many overweight people had their trust clung on... Read Full Story
Acomplia is the brand name of the medication while Rimonabant is the name of its active ingredient. Acomplia (Rimonabant), after its launch in the June 2006, has conquered a vast portion of weight loss drug market. This success of Rimonabant is the result of the benefits which it has given to numerous obese individuals in the European countries. After the UK, presently several other European countries are taking the benefits of Acomplia. Germany, Norway, Denmark, Ireland, Finland and Austria... Read Full Story
21st June 2006. For most people, the day was just like any other day, holding not much importance. But for obese people in the UK, the day will be ever remembered. For on this day, Acomplia, the wonder drug for obesity was released for sale on prescription. Research on acomplia as a diet pill was going on for years. And all eyes were on when the wonder drug will be released.
After Fen-phen, Acomplia diet pill was the most anticipated drug and many overweight people had their trust clung on... Read Full Story
Obesity as such is defined as a disease by the medical community. Though there are certain theories on what causes obesity there has been no concrete proof of it. Thus the theories related to the obesity are vague in nature. To move out of obesity there can be no better method than the age old theory of controlled dieting and physical exercises. But the process is time consuming so many a people leave it for the sake of other options like diet pills, fat burning pills, surgery, liposuction... Read Full Story
Obesity as such is defined as a disease by the medical community. Though there are certain theories on what causes obesity there has been no concrete proof of it. Thus the theories related to the obesity are vague in nature. To move out of obesity there can be no better method than the age old theory of controlled dieting and physical exercises. But the process is time consuming so many a people leave it for the sake of other options like diet pills, fat burning pills, surgery, liposuction... Read Full Story
The big obesity news yesterday was the recommendation of the European Medicines Agency (EMEA) to suspend the marketing authorisation of the CB-1 antagonist Acomplia® (rimonabant) across the European Union (EU).
According to the press release, the EMEA’s Committee for Medicinal Products for Human Use (CHMP) has concluded that the benefits of Acomplia for the treatment of overweight and obese patients no longer outweigh its risks.
Acomplia has been authorised in the EU since June 2006 as... Read Full Story
